Fenofibrate

The company has been granted final approval by the United States Food and Drug Administration (USFDA) for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg, Glenmark Pharmaceuticals said in a statement.

Lupin gets USFDA nod for cholesterol drug

The company has received final approval from the US Food and Drug Administration (USFDA) to market generic version of Teva's Fenofibrate tablets in strengths of 54mg and 160mg, Lupin said in a statement.

Lupin up 8% on USFDA nod for cholesterol drug from Goa unit

Brokerage firm Citi says the US FDA approval of cholesterol drug Fenofibrate is positive as it is filed from its Goa plant and it vindicates management commentary that the observations received by the regulator in July are not disruptive.

About 30% products will be impacted by price control: Lupin

Mumbai based pharma company Lupin says any kind of price control will be a deterrent for the industry and 30 percent of its portfolio will be impacted if government implements price control measures.